Arena: Arena Pharmaceuticals gets grant for treatment of atopic dermatitis with compound 1

Discover the groundbreaking patent by Arena Pharmaceuticals for treating atopic dermatitis with a specific compound in a standard dose. Learn how (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid can revolutionize dermatological treatments.